untreated adult acute lymphoblastic leukemia
Showing 1 - 25 of >10,000
Acute Undifferentiated Leukemia, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia Trial
Completed
- Acute Undifferentiated Leukemia
- +13 more
- allopurinol
- +16 more
-
Chicago, IllinoisCancer and Leukemia Group B
Apr 5, 2022
Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With
Active, not recruiting
- Adult Acute Lymphoblastic Leukemia in Remission
- +14 more
- radiation therapy
- +8 more
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Oct 7, 2022
Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage I Adult
Completed
- Contiguous Stage II Adult Lymphoblastic Lymphoma
- +5 more
- carfilzomib
- +10 more
-
Sacramento, CaliforniaUniversity of California Davis
Mar 8, 2022
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +23 more
- treosulfan
- +7 more
-
Denver, Colorado
- +2 more
Jun 17, 2021
Adult Acute Myeloid Leukemia in Remission, Acute Biphenotypic Leukemia, Early Relapse of Acute Myeloid Leukemia Trial in Duarte
Active, not recruiting
- Adult Acute Myeloid Leukemia in Remission
- +12 more
- cyclophosphamide
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia
- +125 more
- tetanus-CMV fusion peptide vaccine
- laboratory biomarker analysis
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +6 more
- Cyclophosphamide
- +12 more
-
Houston, TexasM D Anderson Cancer Center
Jan 31, 2022
B-cell Acute Lymphoblastic Leukemia Trial (HY004, Cyclophosphamide, Fludarabine Phosphate)
Not yet recruiting
- B-cell Acute Lymphoblastic Leukemia
- HY004
- +2 more
- (no location specified)
Aug 18, 2023
Burkitt Lymphoma, Lymphoblastic Lymphoma, Adult, Acute Lymphoblastic Leukemia, Adult Trial in Zhuhai (Thiotepa,
Recruiting
- Burkitt Lymphoma
- +2 more
- Thiotepa, cyclophosphamide, cladribine, and cytarabine conditioning regimen
-
Zhuhai, Guangdong, ChinaThe Fifth Affiliated Hospital of Sun Yat-sen University
Sep 25, 2023
Acute Lymphoid Leukemia, Minimal Residual Disease, Gene Abnormality Trial in São Paulo (Prednisone, Vincristin, Daunorubicin)
Recruiting
- Acute Lymphoid Leukemia
- +3 more
- Prednisone
- +9 more
-
São Paulo, SP, BrazilInstituto do Cancer do Estado de Sao Paulo
Jul 24, 2023
Determining the Mechanisms of Loss of CAR T Cell Persistence
Not yet recruiting
- Acute Lymphoblastic Leukemia With Failed Remission
- +4 more
- (no location specified)
Mar 29, 2023
Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Trial in Tianjin (Vincristine, Daunorubicin, Cyclophosphamide)
Recruiting
- Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
- Vincristine
- +9 more
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Dec 13, 2022
Acute Undifferentiated Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With
Completed
- Acute Undifferentiated Leukemia
- +10 more
- bioelectric impedance analysis
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Jul 30, 2020
B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- +2 more
- Azacitidine Injection
- +2 more
- (no location specified)
Oct 15, 2023
Acute Lymphoblastic Leukemia, Adult, Invasive Fungal Infections Trial in Rome (observation of invasive fungal infections)
Recruiting
- Acute Lymphoblastic Leukemia, Adult
- Invasive Fungal Infections
- observation of invasive fungal infections
-
Rome, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Feb 20, 2023
Leukemia Trial in Portland (cyclophosphamide, cytarabine, dexamethasone)
Terminated
- Leukemia
- cyclophosphamide
- +8 more
-
Portland, OregonOHSU Knight Cancer Institute
Dec 13, 2022
T-Acute Lymphoblastic Leukemia, Adult T Lymphoblastic Lymphoma Trial in United States (BL-8040, Nelarabine)
Terminated
- T-Acute Lymphoblastic Leukemia
- Adult T Lymphoblastic Lymphoma
-
Saint Louis, Missouri
- +1 more
Jan 18, 2023
Clinical Significance of Occult Central Nervous System
Recruiting
- Acute Lymphoblastic Leukemia
- cerebrospinal fluids exams
-
Roma, RM, ItalyTor Vergata University
Mar 17, 2023
Acute Lymphoblastic Leukemia Trial in New York (Venetoclax)
Recruiting
- Acute Lymphoblastic Leukemia
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 2, 2023
H19 in Acute Lymphoblastic Leukemia.
Not yet recruiting
- Acute Lymphoid Leukemia
- (no location specified)
Jul 11, 2023
B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)
Recruiting
- B-Cell Lymphoblastic Leukemia
- Acute Lymphoblastic Leukemia
-
Tampa, FloridaMoffitt Cancer Center
Nov 28, 2023
Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission Trial in São Paulo (Bortezomib)
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- Acute Lymphoblastic Leukemia With Failed Remission
-
São Paulo, SP, BrazilInstituto do Cancer do Estado de Sao Paulo
Sep 12, 2023
Acute Lymphoblastic Leukemia Trial in Ann Arbor (Dasatinib, Ponatinib, Berlin-Frankfurt-Münster Chemotherapy)
Recruiting
- Acute Lymphoblastic Leukemia
- Dasatinib
- +3 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Nov 28, 2022
T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)
Not yet recruiting
- T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
- CD7-CART01
- (no location specified)
Sep 26, 2023
Acute T-lymphoblastic Leukemia, Acute T-lymphoblastic Lymphoma Trial in Xuzhou (CAR-T Cell Infusion)
Recruiting
- Acute T-lymphoblastic Leukemia
- Acute T-lymphoblastic Lymphoma
- CAR-T Cell Infusion
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Feb 23, 2023